5DJA image
Entry Detail
PDB ID:
5DJA
Keywords:
Title:
Fc Heterodimer Design 9.1 Y407M + T366I
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2015-09-01
Release Date:
2016-03-30
Method Details:
Experimental Method:
Resolution:
2.90 Å
R-Value Free:
0.28
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Ig gamma-1 chain C region
Mutations:Y407M
Chain IDs:A
Chain Length:227
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Ig gamma-1 chain C region
Mutations:T366I
Chain IDs:B
Chain Length:240
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Fc-III peptide
Chain IDs:C
Chain Length:13
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Computationally Designed Bispecific Antibodies using Negative State Repertoires.
Structure 24 641 651 (2016)
PMID: 26996964 DOI: 10.1016/j.str.2016.02.013

Abstact

A challenge in the structure-based design of specificity is modeling the negative states, i.e., the complexes that you do not want to form. This is a difficult problem because mutations predicted to destabilize the negative state might be accommodated by small conformational rearrangements. To overcome this challenge, we employ an iterative strategy that cycles between sequence design and protein docking in order to build up an ensemble of alternative negative state conformations for use in specificity prediction. We have applied our technique to the design of heterodimeric CH3 interfaces in the Fc region of antibodies. Combining computationally and rationally designed mutations produced unique designs with heterodimer purities greater than 90%. Asymmetric Fc crystallization was able to resolve the interface mutations; the heterodimer structures confirmed that the interfaces formed as designed. With these CH3 mutations, and those made at the heavy-/light-chain interface, we demonstrate one-step synthesis of four fully IgG-bispecific antibodies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures